Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease

European Journal of Cancer Part A

Volumn 32, Issue 7, 1996, Pages 1262-

  Tenenbaum, F ^a   Corone, C ^a   Schlumberger, M ^a   Parmentier, C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; RADIOACTIVE IODINE; THYROGLOBULIN; TUMOR MARKER;

BLOOD; HUMAN; LETTER; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY;

HUMANS; IODINE RADIOISOTOPES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 33748115432     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00020-2     Document Type: Letter

References (3)

1. Schlumberger M, Fragu P, Gardet P, Lumbroso J, Violot D, Parmentier C. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. EurJNuclMed 1991, 18, 153-157.
2. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung métastases of differentiated thyroid carcinoma in patients with normal chest X-rays. JNudMed 1988, 29, 1790-1794.
3. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine131 reveal undiagnosed métastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987, 28, 1888-1891.